HuGE Literature Finder
Records
1
-
3
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia. Blood 2022 2 139 (24): 3519-3531. Kimura Shunsuke, Montefiori Lindsey, Iacobucci Ilaria, Zhao Yaqi, Gao Qingsong, Paietta Elisabeth M, Haferlach Claudia, Laird A Douglas, Mead Paul E, Gu Zhaohui, Stock Wendy, Litzow Mark, Rowe Jacob M, Luger Selina M, Hunger Stephen P, Ryland Georgina L, Schmidt Breon, Ekert Paul G, Oshlack Alicia, Grimmond Sean M, Rehn Jacqueline, Breen James, Yeung David, White Deborah L, Aldoss Ibrahim, Jabbour Elias J, Pui Ching-Hon, Meggendorfer Manja, Walter Wencke, Kern Wolfgang, Haferlach Torsten, Brady Samuel, Zhang Jinghui, Roberts Kathryn G, Blombery Piers, Mullighan Charles |
13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking. Blood 2020 May . Yang Minjun, Safavi Setareh, Woodward Eleanor L, Duployez Nicolas, Olsson-Arvidsson Linda, Ungerbäck Jonas, Sigvardsson Mikael, Zaliova Marketa, Zuna Jan, Fioretos Thoas, Johansson Bertil, Nord Karolin H, Paulsson Kaj |
Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011. Leukemia 2014 Feb 28 (2): 302-10. Olsson L, Castor A, Behrendtz M, Biloglav A, Forestier E, Paulsson K, Johansson |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: